The global market for Medical Foods for Inborn Errors of Metabolism was estimated to be worth US$ 823 million in 2023 and is forecast to a readjusted size of US$ 1185.9 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030

Medical Foods for Inborn Errors of Metabolism - Market

Diet therapy is the traditional method of inborn errors of metabolism. Medical food is the specialized food formulated to be consumed under physician supervision and intended for specific dietary management of a particular disease or condition. Inborn errors of metabolism refer to inherited disorders due to mutation in genes coding for proteins functioning in metabolism. The inborn errors of metabolism are a heterogeneous group of disorders and are likely to be inherited through spontaneous mutation. The diseases usually involve failure of metabolic pathways that are either involved in breakdown or storage of biomolecules, such as carbohydrates, proteins, and fatty acids.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medical Foods for Inborn Errors of Metabolism, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Medical Foods for Inborn Errors of Metabolism by region & country, by Type, and by Application.

The Medical Foods for Inborn Errors of Metabolism market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Foods for Inborn Errors of Metabolism.

Market Segmentation

Scope of Medical Foods for Inborn Errors of Metabolism - Market Report

Report Metric	Details
Report Name	Medical Foods for Inborn Errors of Metabolism - Market
Forecasted market size in 2030	US$ 1185.9 million
CAGR	5.4%
Forecasted years	2024 - 2030
Segment by Type:	Amino Acid Glytactin with GMP Amino Acid-Modified Infant Formula With Iron Low Protein Food Others
Segment by Application	Phenylketonuria (PKU) Maple Syrup Urine Disease (MSUD) Urea Cycle Disorders Renal Disease Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Nestlé, Abbott, Reckitt Benckiser Group, Ajinomoto, Solace Nutrition, Primus Pharmaceuticals, BioMarin Pharmaceutical, Danone SA, Galen Limited, PKU-MDMIL
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Foods for Inborn Errors of Metabolism manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Medical Foods for Inborn Errors of Metabolism in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Medical Foods for Inborn Errors of Metabolism in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Medical Foods for Inborn Errors of Metabolism - Market size in 2030?

Ans: The Medical Foods for Inborn Errors of Metabolism - Market size in 2030 will be US$ 1185.9 million.

Who are the main players in the Medical Foods for Inborn Errors of Metabolism - Market report?

Ans: The main players in the Medical Foods for Inborn Errors of Metabolism - Market are Nestlé, Abbott, Reckitt Benckiser Group, Ajinomoto, Solace Nutrition, Primus Pharmaceuticals, BioMarin Pharmaceutical, Danone SA, Galen Limited, PKU-MDMIL

What are the Application segmentation covered in the Medical Foods for Inborn Errors of Metabolism - Market report?

Ans: The Applications covered in the Medical Foods for Inborn Errors of Metabolism - Market report are Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Urea Cycle Disorders, Renal Disease, Others

What are the Type segmentation covered in the Medical Foods for Inborn Errors of Metabolism - Market report?

Ans: The Types covered in the Medical Foods for Inborn Errors of Metabolism - Market report are Amino Acid, Glytactin with GMP, Amino Acid-Modified Infant Formula With Iron, Low Protein Food, Others

1 Market Overview

1.1 Medical Foods for Inborn Errors of Metabolism Product Introduction

1.2 Global Medical Foods for Inborn Errors of Metabolism Market Size Forecast

1.2.1 Global Medical Foods for Inborn Errors of Metabolism Sales Value (2019-2030)

1.2.2 Global Medical Foods for Inborn Errors of Metabolism Sales Volume (2019-2030)

1.2.3 Global Medical Foods for Inborn Errors of Metabolism Sales Price (2019-2030)

1.3 Medical Foods for Inborn Errors of Metabolism Market Trends & Drivers

1.3.1 Medical Foods for Inborn Errors of Metabolism Industry Trends

1.3.2 Medical Foods for Inborn Errors of Metabolism Market Drivers & Opportunity

1.3.3 Medical Foods for Inborn Errors of Metabolism Market Challenges

1.3.4 Medical Foods for Inborn Errors of Metabolism Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Medical Foods for Inborn Errors of Metabolism Players Revenue Ranking (2023)

2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Company (2019-2024)

2.3 Global Medical Foods for Inborn Errors of Metabolism Players Sales Volume Ranking (2023)

2.4 Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Company Players (2019-2024)

2.5 Global Medical Foods for Inborn Errors of Metabolism Average Price by Company (2019-2024)

2.6 Key Manufacturers Medical Foods for Inborn Errors of Metabolism Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Medical Foods for Inborn Errors of Metabolism Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Medical Foods for Inborn Errors of Metabolism

2.9 Medical Foods for Inborn Errors of Metabolism Market Competitive Analysis

2.9.1 Medical Foods for Inborn Errors of Metabolism Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Medical Foods for Inborn Errors of Metabolism Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Foods for Inborn Errors of Metabolism as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Amino Acid

3.1.2 Glytactin with GMP

3.1.3 Amino Acid-Modified Infant Formula With Iron

3.1.4 Low Protein Food

3.1.5 Others

3.2 Global Medical Foods for Inborn Errors of Metabolism Sales Value by Type

3.2.1 Global Medical Foods for Inborn Errors of Metabolism Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Medical Foods for Inborn Errors of Metabolism Sales Value, by Type (2019-2030)

3.2.3 Global Medical Foods for Inborn Errors of Metabolism Sales Value, by Type (%) (2019-2030)

3.3 Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Type

3.3.1 Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Medical Foods for Inborn Errors of Metabolism Sales Volume, by Type (2019-2030)

3.3.3 Global Medical Foods for Inborn Errors of Metabolism Sales Volume, by Type (%) (2019-2030)

3.4 Global Medical Foods for Inborn Errors of Metabolism Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Phenylketonuria (PKU)

4.1.2 Maple Syrup Urine Disease (MSUD)

4.1.3 Urea Cycle Disorders

4.1.4 Renal Disease

4.1.5 Others

4.2 Global Medical Foods for Inborn Errors of Metabolism Sales Value by Application

4.2.1 Global Medical Foods for Inborn Errors of Metabolism Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Medical Foods for Inborn Errors of Metabolism Sales Value, by Application (2019-2030)

4.2.3 Global Medical Foods for Inborn Errors of Metabolism Sales Value, by Application (%) (2019-2030)

4.3 Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Application

4.3.1 Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Medical Foods for Inborn Errors of Metabolism Sales Volume, by Application (2019-2030)

4.3.3 Global Medical Foods for Inborn Errors of Metabolism Sales Volume, by Application (%) (2019-2030)

4.4 Global Medical Foods for Inborn Errors of Metabolism Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Medical Foods for Inborn Errors of Metabolism Sales Value by Region

5.1.1 Global Medical Foods for Inborn Errors of Metabolism Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Medical Foods for Inborn Errors of Metabolism Sales Value by Region (2019-2024)

5.1.3 Global Medical Foods for Inborn Errors of Metabolism Sales Value by Region (2025-2030)

5.1.4 Global Medical Foods for Inborn Errors of Metabolism Sales Value by Region (%), (2019-2030)

5.2 Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Region

5.2.1 Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Region (2019-2024)

5.2.3 Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Region (2025-2030)

5.2.4 Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Region (%), (2019-2030)

5.3 Global Medical Foods for Inborn Errors of Metabolism Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Medical Foods for Inborn Errors of Metabolism Sales Value, 2019-2030

5.4.2 North America Medical Foods for Inborn Errors of Metabolism Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Medical Foods for Inborn Errors of Metabolism Sales Value, 2019-2030

5.5.2 Europe Medical Foods for Inborn Errors of Metabolism Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales Value, 2019-2030

5.6.2 Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Medical Foods for Inborn Errors of Metabolism Sales Value, 2019-2030

5.7.2 South America Medical Foods for Inborn Errors of Metabolism Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales Value, 2019-2030

5.8.2 Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Medical Foods for Inborn Errors of Metabolism Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Medical Foods for Inborn Errors of Metabolism Sales Value

6.2.1 Key Countries/Regions Medical Foods for Inborn Errors of Metabolism Sales Value, 2019-2030

6.2.2 Key Countries/Regions Medical Foods for Inborn Errors of Metabolism Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Medical Foods for Inborn Errors of Metabolism Sales Value, 2019-2030

6.3.2 United States Medical Foods for Inborn Errors of Metabolism Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Medical Foods for Inborn Errors of Metabolism Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Medical Foods for Inborn Errors of Metabolism Sales Value, 2019-2030

6.4.2 Europe Medical Foods for Inborn Errors of Metabolism Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Medical Foods for Inborn Errors of Metabolism Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Medical Foods for Inborn Errors of Metabolism Sales Value, 2019-2030

6.5.2 China Medical Foods for Inborn Errors of Metabolism Sales Value by Type (%), 2023 VS 2030

6.5.3 China Medical Foods for Inborn Errors of Metabolism Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Medical Foods for Inborn Errors of Metabolism Sales Value, 2019-2030

6.6.2 Japan Medical Foods for Inborn Errors of Metabolism Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Medical Foods for Inborn Errors of Metabolism Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Medical Foods for Inborn Errors of Metabolism Sales Value, 2019-2030

6.7.2 South Korea Medical Foods for Inborn Errors of Metabolism Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Medical Foods for Inborn Errors of Metabolism Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Medical Foods for Inborn Errors of Metabolism Sales Value, 2019-2030

6.8.2 Southeast Asia Medical Foods for Inborn Errors of Metabolism Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Medical Foods for Inborn Errors of Metabolism Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Medical Foods for Inborn Errors of Metabolism Sales Value, 2019-2030

6.9.2 India Medical Foods for Inborn Errors of Metabolism Sales Value by Type (%), 2023 VS 2030

6.9.3 India Medical Foods for Inborn Errors of Metabolism Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Nestlé

7.1.1 Nestlé Company Information

7.1.2 Nestlé Introduction and Business Overview

7.1.3 Nestlé Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Nestlé Medical Foods for Inborn Errors of Metabolism Product Offerings

7.1.5 Nestlé Recent Development

7.2 Abbott

7.2.1 Abbott Company Information

7.2.2 Abbott Introduction and Business Overview

7.2.3 Abbott Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Abbott Medical Foods for Inborn Errors of Metabolism Product Offerings

7.2.5 Abbott Recent Development

7.3 Reckitt Benckiser Group

7.3.1 Reckitt Benckiser Group Company Information

7.3.2 Reckitt Benckiser Group Introduction and Business Overview

7.3.3 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Product Offerings

7.3.5 Reckitt Benckiser Group Recent Development

7.4 Ajinomoto

7.4.1 Ajinomoto Company Information

7.4.2 Ajinomoto Introduction and Business Overview

7.4.3 Ajinomoto Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Ajinomoto Medical Foods for Inborn Errors of Metabolism Product Offerings

7.4.5 Ajinomoto Recent Development

7.5 Solace Nutrition

7.5.1 Solace Nutrition Company Information

7.5.2 Solace Nutrition Introduction and Business Overview

7.5.3 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Product Offerings

7.5.5 Solace Nutrition Recent Development

7.6 Primus Pharmaceuticals

7.6.1 Primus Pharmaceuticals Company Information

7.6.2 Primus Pharmaceuticals Introduction and Business Overview

7.6.3 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Product Offerings

7.6.5 Primus Pharmaceuticals Recent Development

7.7 BioMarin Pharmaceutical

7.7.1 BioMarin Pharmaceutical Company Information

7.7.2 BioMarin Pharmaceutical Introduction and Business Overview

7.7.3 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)

7.7.4 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Product Offerings

7.7.5 BioMarin Pharmaceutical Recent Development

7.8 Danone SA

7.8.1 Danone SA Company Information

7.8.2 Danone SA Introduction and Business Overview

7.8.3 Danone SA Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Danone SA Medical Foods for Inborn Errors of Metabolism Product Offerings

7.8.5 Danone SA Recent Development

7.9 Galen Limited

7.9.1 Galen Limited Company Information

7.9.2 Galen Limited Introduction and Business Overview

7.9.3 Galen Limited Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Galen Limited Medical Foods for Inborn Errors of Metabolism Product Offerings

7.9.5 Galen Limited Recent Development

7.10 PKU-MDMIL

7.10.1 PKU-MDMIL Company Information

7.10.2 PKU-MDMIL Introduction and Business Overview

7.10.3 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)

7.10.4 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Product Offerings

7.10.5 PKU-MDMIL Recent Development

8 Industry Chain Analysis

8.1 Medical Foods for Inborn Errors of Metabolism Industrial Chain

8.2 Medical Foods for Inborn Errors of Metabolism Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Medical Foods for Inborn Errors of Metabolism Sales Model

8.5.2 Sales Channel

8.5.3 Medical Foods for Inborn Errors of Metabolism Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Nestlé

Abbott

Reckitt Benckiser Group

Ajinomoto

Solace Nutrition

Primus Pharmaceuticals

BioMarin Pharmaceutical

Danone SA

Galen

PKU-MDMIL

List of Tables

Table 1. Medical Foods for Inborn Errors of Metabolism Market Trends

Table 2. Medical Foods for Inborn Errors of Metabolism Market Drivers & Opportunity

Table 3. Medical Foods for Inborn Errors of Metabolism Market Challenges

Table 4. Medical Foods for Inborn Errors of Metabolism Market Restraints

Table 5. Global Medical Foods for Inborn Errors of Metabolism Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Company (2019-2024)

Table 7. Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Medical Foods for Inborn Errors of Metabolism Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Medical Foods for Inborn Errors of Metabolism Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Medical Foods for Inborn Errors of Metabolism Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Medical Foods for Inborn Errors of Metabolism Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Medical Foods for Inborn Errors of Metabolism

Table 13. Global Medical Foods for Inborn Errors of Metabolism Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Foods for Inborn Errors of Metabolism as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Medical Foods for Inborn Errors of Metabolism Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Medical Foods for Inborn Errors of Metabolism Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Medical Foods for Inborn Errors of Metabolism Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Medical Foods for Inborn Errors of Metabolism Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Medical Foods for Inborn Errors of Metabolism Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Medical Foods for Inborn Errors of Metabolism Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Medical Foods for Inborn Errors of Metabolism Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Medical Foods for Inborn Errors of Metabolism Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Medical Foods for Inborn Errors of Metabolism Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Medical Foods for Inborn Errors of Metabolism Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Medical Foods for Inborn Errors of Metabolism Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Medical Foods for Inborn Errors of Metabolism Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Medical Foods for Inborn Errors of Metabolism Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Medical Foods for Inborn Errors of Metabolism Sales Value by Region (2019-2024) & (%)

Table 44. Global Medical Foods for Inborn Errors of Metabolism Sales Value by Region (2025-2030) & (%)

Table 45. Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Region (2019-2024) & (%)

Table 49. Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Region (2025-2030) & (%)

Table 50. Global Medical Foods for Inborn Errors of Metabolism Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Medical Foods for Inborn Errors of Metabolism Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Medical Foods for Inborn Errors of Metabolism Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Medical Foods for Inborn Errors of Metabolism Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Medical Foods for Inborn Errors of Metabolism Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Medical Foods for Inborn Errors of Metabolism Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Medical Foods for Inborn Errors of Metabolism Sales Volume, (2025-2030) & (K Units)

Table 57. Nestlé Company Information

Table 58. Nestlé Introduction and Business Overview

Table 59. Nestlé Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Nestlé Medical Foods for Inborn Errors of Metabolism Product Offerings

Table 61. Nestlé Recent Development

Table 62. Abbott Company Information

Table 63. Abbott Introduction and Business Overview

Table 64. Abbott Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Abbott Medical Foods for Inborn Errors of Metabolism Product Offerings

Table 66. Abbott Recent Development

Table 67. Reckitt Benckiser Group Company Information

Table 68. Reckitt Benckiser Group Introduction and Business Overview

Table 69. Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Product Offerings

Table 71. Reckitt Benckiser Group Recent Development

Table 72. Ajinomoto Company Information

Table 73. Ajinomoto Introduction and Business Overview

Table 74. Ajinomoto Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Ajinomoto Medical Foods for Inborn Errors of Metabolism Product Offerings

Table 76. Ajinomoto Recent Development

Table 77. Solace Nutrition Company Information

Table 78. Solace Nutrition Introduction and Business Overview

Table 79. Solace Nutrition Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Solace Nutrition Medical Foods for Inborn Errors of Metabolism Product Offerings

Table 81. Solace Nutrition Recent Development

Table 82. Primus Pharmaceuticals Company Information

Table 83. Primus Pharmaceuticals Introduction and Business Overview

Table 84. Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Product Offerings

Table 86. Primus Pharmaceuticals Recent Development

Table 87. BioMarin Pharmaceutical Company Information

Table 88. BioMarin Pharmaceutical Introduction and Business Overview

Table 89. BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Product Offerings

Table 91. BioMarin Pharmaceutical Recent Development

Table 92. Danone SA Company Information

Table 93. Danone SA Introduction and Business Overview

Table 94. Danone SA Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Danone SA Medical Foods for Inborn Errors of Metabolism Product Offerings

Table 96. Danone SA Recent Development

Table 97. Galen Limited Company Information

Table 98. Galen Limited Introduction and Business Overview

Table 99. Galen Limited Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Galen Limited Medical Foods for Inborn Errors of Metabolism Product Offerings

Table 101. Galen Limited Recent Development

Table 102. PKU-MDMIL Company Information

Table 103. PKU-MDMIL Introduction and Business Overview

Table 104. PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Product Offerings

Table 106. PKU-MDMIL Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Medical Foods for Inborn Errors of Metabolism Downstream Customers

Table 110. Medical Foods for Inborn Errors of Metabolism Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Medical Foods for Inborn Errors of Metabolism Product Picture

Figure 2. Global Medical Foods for Inborn Errors of Metabolism Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Medical Foods for Inborn Errors of Metabolism Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Medical Foods for Inborn Errors of Metabolism Sales Volume (2019-2030) & (K Units)

Figure 5. Global Medical Foods for Inborn Errors of Metabolism Sales Price (2019-2030) & (US$/Unit)

Figure 6. Medical Foods for Inborn Errors of Metabolism Report Years Considered

Figure 7. Global Medical Foods for Inborn Errors of Metabolism Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Medical Foods for Inborn Errors of Metabolism Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Medical Foods for Inborn Errors of Metabolism Revenue in 2023

Figure 10. Medical Foods for Inborn Errors of Metabolism Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Amino Acid Picture

Figure 12. Glytactin with GMP Picture

Figure 13. Amino Acid-Modified Infant Formula With Iron Picture

Figure 14. Low Protein Food Picture

Figure 15. Others Picture

Figure 16. Global Medical Foods for Inborn Errors of Metabolism Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Medical Foods for Inborn Errors of Metabolism Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 19. Global Medical Foods for Inborn Errors of Metabolism Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Medical Foods for Inborn Errors of Metabolism Price by Type (2019-2030) & (US$/Unit)

Figure 21. Product Picture of Phenylketonuria (PKU)

Figure 22. Product Picture of Maple Syrup Urine Disease (MSUD)

Figure 23. Product Picture of Urea Cycle Disorders

Figure 24. Product Picture of Renal Disease

Figure 25. Product Picture of Others

Figure 26. Global Medical Foods for Inborn Errors of Metabolism Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 27. Global Medical Foods for Inborn Errors of Metabolism Sales Value Market Share by Application, 2023 & 2030

Figure 28. Global Medical Foods for Inborn Errors of Metabolism Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 29. Global Medical Foods for Inborn Errors of Metabolism Sales Volume Market Share by Application, 2023 & 2030

Figure 30. Global Medical Foods for Inborn Errors of Metabolism Price by Application (2019-2030) & (US$/Unit)

Figure 31. North America Medical Foods for Inborn Errors of Metabolism Sales Value (2019-2030) & (US$ Million)

Figure 32. North America Medical Foods for Inborn Errors of Metabolism Sales Value by Country (%), 2023 VS 2030

Figure 33. Europe Medical Foods for Inborn Errors of Metabolism Sales Value (2019-2030) & (US$ Million)

Figure 34. Europe Medical Foods for Inborn Errors of Metabolism Sales Value by Country (%), 2023 VS 2030

Figure 35. Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales Value (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales Value by Country (%), 2023 VS 2030

Figure 37. South America Medical Foods for Inborn Errors of Metabolism Sales Value (2019-2030) & (US$ Million)

Figure 38. South America Medical Foods for Inborn Errors of Metabolism Sales Value by Country (%), 2023 VS 2030

Figure 39. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales Value (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales Value by Country (%), 2023 VS 2030

Figure 41. Key Countries/Regions Medical Foods for Inborn Errors of Metabolism Sales Value (%), (2019-2030)

Figure 42. Key Countries/Regions Medical Foods for Inborn Errors of Metabolism Sales Volume (%), (2019-2030)

Figure 43. United States Medical Foods for Inborn Errors of Metabolism Sales Value, (2019-2030) & (US$ Million)

Figure 44. United States Medical Foods for Inborn Errors of Metabolism Sales Value by Type (%), 2023 VS 2030

Figure 45. United States Medical Foods for Inborn Errors of Metabolism Sales Value by Application (%), 2023 VS 2030

Figure 46. Europe Medical Foods for Inborn Errors of Metabolism Sales Value, (2019-2030) & (US$ Million)

Figure 47. Europe Medical Foods for Inborn Errors of Metabolism Sales Value by Type (%), 2023 VS 2030

Figure 48. Europe Medical Foods for Inborn Errors of Metabolism Sales Value by Application (%), 2023 VS 2030

Figure 49. China Medical Foods for Inborn Errors of Metabolism Sales Value, (2019-2030) & (US$ Million)

Figure 50. China Medical Foods for Inborn Errors of Metabolism Sales Value by Type (%), 2023 VS 2030

Figure 51. China Medical Foods for Inborn Errors of Metabolism Sales Value by Application (%), 2023 VS 2030

Figure 52. Japan Medical Foods for Inborn Errors of Metabolism Sales Value, (2019-2030) & (US$ Million)

Figure 53. Japan Medical Foods for Inborn Errors of Metabolism Sales Value by Type (%), 2023 VS 2030

Figure 54. Japan Medical Foods for Inborn Errors of Metabolism Sales Value by Application (%), 2023 VS 2030

Figure 55. South Korea Medical Foods for Inborn Errors of Metabolism Sales Value, (2019-2030) & (US$ Million)

Figure 56. South Korea Medical Foods for Inborn Errors of Metabolism Sales Value by Type (%), 2023 VS 2030

Figure 57. South Korea Medical Foods for Inborn Errors of Metabolism Sales Value by Application (%), 2023 VS 2030

Figure 58. Southeast Asia Medical Foods for Inborn Errors of Metabolism Sales Value, (2019-2030) & (US$ Million)

Figure 59. Southeast Asia Medical Foods for Inborn Errors of Metabolism Sales Value by Type (%), 2023 VS 2030

Figure 60. Southeast Asia Medical Foods for Inborn Errors of Metabolism Sales Value by Application (%), 2023 VS 2030

Figure 61. India Medical Foods for Inborn Errors of Metabolism Sales Value, (2019-2030) & (US$ Million)

Figure 62. India Medical Foods for Inborn Errors of Metabolism Sales Value by Type (%), 2023 VS 2030

Figure 63. India Medical Foods for Inborn Errors of Metabolism Sales Value by Application (%), 2023 VS 2030

Figure 64. Medical Foods for Inborn Errors of Metabolism Industrial Chain

Figure 65. Medical Foods for Inborn Errors of Metabolism Manufacturing Cost Structure

Figure 66. Channels of Distribution (Direct Sales, and Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions